The Everyman Male Cancer Campaign

Facts about male cancer

Testicular cancer is the most common cancer in young men aged 15-44 but is now 99% curable if caught early enough, so awareness can literally save lives
Prostate cancer kills one man every hour in the UK
Prostate cancer affects men 50 years+ and has now overtaken lung cancer as the most common cancer in men in the UK
Awareness of these cancers and their symptoms is low amongst men and women

The Everyman Male Cancer Campaign

The incidence of male cancer is rising rapidly, yet we still do not know why. Despite this, and the fact that it affects so many men in the UK, research into male cancer is severely under-funded and is 10 years behind some other cancers.

Everyman is a campaign run by The Institute of Cancer Research, dedicated to raising awareness of and funding research into prostate and testicular cancer, which together, affect around 37,000 men in the UK each year.

In 2000, Everyman set up Europe’s only dedicated male cancer research centre to investigate the causes of these cancers and to improve diagnosis and treatment and has been designated as a Centre of Excellence by the Government.

Keep Your Eye on the Ball – Everyman in partnership with The FA and The PFA

The Keep Your Eye on the Ball campaign was established in 2000 by The FA, The PFA and Everyman, to raise awareness of male cancer within the football community, as well as vital funds for our research at The Everyman Centre.

Male cancer has affected high-profile players within the football community – Jason Cundy, Alan Stubbs, Neil Harris, Craig Forrest, Ray Clemence and Matt Duke are some of the players who have talked openly about their experiences and supported the KYEOTB campaign.

Everyman achievements to date

Our scientists work on a world-leading extensive programme of research into prostate and testicular cancer. Here are some examples of their work:
Development of Abiraterone – hailed as one of the largest developments in prostate cancer research in the last 50 years. This drug can treat up to 80% of patients with aggressive and previously drug-resistant prostate cancer and we are hopeful that, in the next four years it will be available to provide treatment for thousands of men worldwide.
Development of Carboplatin – has led to a 99% cure rate for testicular cancer (if caught early enough)
Identification of the BRCA2 gene which can determine a pre

I support Keep Your Eye On The Ball because it is important to make the fans and players aware of male cancer. Testicular cancer is the most common cancer to affect men between 15-44 years old, the average career span of a footballer. The good news is though that if caught early enough, it is curable in 99% of cases. That’s why it is important http://chello.images.infostradasports.com/images/lib/news/large/PRO_123633_RonaldinhoBarcelona.jpgfor Keep Your Eye On The Ball to continue to raise awareness, which will help save lives.
David James